Should Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency Genotype SZ Receive Augmentation Therapy? A Pro/Con Debate. // Archivos de Bronconeumología. – URL: https://www.sciencedirect.com/science/article/pii/S0300289626003613?dgcid=rss_sd_all
Should Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency Genotype SZ Receive Augmentation Therapy? A Pro/Con Debate. Archivos de Bronconeumología. https://www.sciencedirect.com/science/article/pii/S0300289626003613?dgcid=rss_sd_all
“Should Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency Genotype SZ Receive Augmentation Therapy? A Pro/Con Debate.” Archivos de Bronconeumología.
@article{article36843,
title = {Should Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency Genotype SZ Receive Augmentation Therapy? A Pro/Con Debate},
journal = {Archivos de Bronconeumología},
url = {https://www.sciencedirect.com/science/article/pii/S0300289626003613?dgcid=rss_sd_all}
}